SE431545B - Forfarande for framstellning av nya 2-substituerade oxazolopyridiner - Google Patents
Forfarande for framstellning av nya 2-substituerade oxazolopyridinerInfo
- Publication number
- SE431545B SE431545B SE7608037A SE7608037A SE431545B SE 431545 B SE431545 B SE 431545B SE 7608037 A SE7608037 A SE 7608037A SE 7608037 A SE7608037 A SE 7608037A SE 431545 B SE431545 B SE 431545B
- Authority
- SE
- Sweden
- Prior art keywords
- oxazolopyridines
- substituted
- procedure
- preparation
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
- C07C205/49—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups
- C07C205/57—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by carboxyl groups having nitro groups and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C63/00—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings
- C07C63/68—Compounds having carboxyl groups bound to a carbon atoms of six-membered aromatic rings containing halogen
- C07C63/72—Polycyclic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/600,169 US4011326A (en) | 1975-07-29 | 1975-07-29 | 2-Substituted oxazolo[4,5-b]pyridine anti-inflammatory agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7608037L SE7608037L (sv) | 1977-01-30 |
| SE431545B true SE431545B (sv) | 1984-02-13 |
Family
ID=24402575
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7608037A SE431545B (sv) | 1975-07-29 | 1976-07-14 | Forfarande for framstellning av nya 2-substituerade oxazolopyridiner |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US4011326A (sv) |
| JP (1) | JPS6037116B2 (sv) |
| AU (1) | AU505159B2 (sv) |
| BE (1) | BE844577A (sv) |
| CH (1) | CH603661A5 (sv) |
| DE (1) | DE2633905A1 (sv) |
| DK (1) | DK320276A (sv) |
| ES (1) | ES450245A1 (sv) |
| FR (1) | FR2319354A1 (sv) |
| GB (1) | GB1497985A (sv) |
| HU (1) | HU172167B (sv) |
| NL (1) | NL7607794A (sv) |
| SE (1) | SE431545B (sv) |
| ZA (1) | ZA764527B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH085368Y2 (ja) * | 1987-03-05 | 1996-02-14 | 日産自動車株式会社 | 内燃機関のコネクティングロッド |
| DK0937075T3 (da) * | 1996-11-11 | 2004-04-13 | Altana Pharma Ag | Hidtil ukendte imidazo- og oxazolopyridiner som phosphodiesteraseinhibitorer |
| CZ20033037A3 (cs) | 2001-05-15 | 2004-06-16 | F. Hoffmann-La Roche Ag | Karboxylové kyselinou odvozené od substituovaných oxazolových derivátů pro použití jako PPAR-alfa a -gama aktivátory při léčbě diabetu |
| DE60234057D1 (de) | 2001-07-25 | 2009-11-26 | Raptor Pharmaceutical Inc | Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke |
| CN100402510C (zh) * | 2002-07-03 | 2008-07-16 | 霍夫曼-拉罗奇有限公司 | 噁唑衍生物及其作为胰岛素敏化剂的应用 |
| RU2296754C2 (ru) * | 2002-08-30 | 2007-04-10 | Ф.Хоффманн-Ля Рош Аг | НОВЫЕ СОЕДИНЕНИЯ 2-АРИЛТИАЗОЛА В КАЧЕСТВЕ АГОНИСТОВ PPAR α И PPAR γ |
| SI1539746T1 (sl) * | 2002-09-12 | 2007-04-30 | Hoffmann La Roche | Spojine n-substituirane-1h-indol-5-propionske kisline kot agonisti ppar, ki so uporabne za zdravljenje diabetesa |
| KR100713266B1 (ko) * | 2002-11-25 | 2007-05-04 | 에프. 호프만-라 로슈 아게 | 인돌릴 유도체 |
| EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
| US8795627B2 (en) | 2007-03-21 | 2014-08-05 | Raptor Pharmaceuticals Inc. | Treatment of liver disorders by administration of RAP conjugates |
| AU2010216512B2 (en) | 2009-02-20 | 2016-06-30 | 2-Bbb Medicines B.V. | Glutathione-based drug delivery system |
| WO2010129819A2 (en) | 2009-05-06 | 2010-11-11 | Laboratory Skin Care, Inc. | Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3935195A (en) * | 1969-04-28 | 1976-01-27 | Sterling Drug Inc. | 4,4'-Stilbenebis-pyridooxazoles and related optical brighteners and polymeric compositions brightened thereby |
| FR2148362A1 (en) * | 1971-08-11 | 1973-03-23 | Ferlux | 2-amino-(4,5-b)-oxazolopyridine cpds - with analgesic,anti-inflammato anticonvulsant,muscle relaxant and diuretic activity |
| AR208500A1 (es) * | 1972-06-14 | 1977-02-15 | Merck & Co Inc | Procedimiento para la preparacion de derivados de oxazolo(4,5-b)-piridinas |
-
1975
- 1975-07-29 US US05/600,169 patent/US4011326A/en not_active Expired - Lifetime
-
1976
- 1976-07-14 SE SE7608037A patent/SE431545B/sv not_active IP Right Cessation
- 1976-07-14 NL NL7607794A patent/NL7607794A/xx not_active Application Discontinuation
- 1976-07-15 DK DK320276A patent/DK320276A/da not_active Application Discontinuation
- 1976-07-20 AU AU16052/76A patent/AU505159B2/en not_active Expired
- 1976-07-22 FR FR7622378A patent/FR2319354A1/fr active Granted
- 1976-07-23 CH CH947876A patent/CH603661A5/xx not_active IP Right Cessation
- 1976-07-26 GB GB31065/76A patent/GB1497985A/en not_active Expired
- 1976-07-28 DE DE19762633905 patent/DE2633905A1/de not_active Ceased
- 1976-07-28 BE BE169289A patent/BE844577A/xx not_active IP Right Cessation
- 1976-07-28 ZA ZA00764527A patent/ZA764527B/xx unknown
- 1976-07-28 ES ES450245A patent/ES450245A1/es not_active Expired
- 1976-07-28 HU HU76ME00002006A patent/HU172167B/hu unknown
- 1976-07-29 JP JP51089756A patent/JPS6037116B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| AU1605276A (en) | 1978-01-26 |
| NL7607794A (nl) | 1977-02-01 |
| FR2319354B1 (sv) | 1979-07-20 |
| GB1497985A (en) | 1978-01-12 |
| DE2633905A1 (de) | 1977-02-17 |
| JPS5217495A (en) | 1977-02-09 |
| AU505159B2 (en) | 1979-11-08 |
| HU172167B (hu) | 1978-06-28 |
| ES450245A1 (es) | 1979-05-16 |
| BE844577A (fr) | 1977-01-28 |
| US4011326A (en) | 1977-03-08 |
| DK320276A (da) | 1977-01-30 |
| ZA764527B (en) | 1978-03-29 |
| JPS6037116B2 (ja) | 1985-08-24 |
| SE7608037L (sv) | 1977-01-30 |
| CH603661A5 (sv) | 1978-08-31 |
| FR2319354A1 (fr) | 1977-02-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
| SE7513571L (sv) | Forfarande for framstellning av nya substituerade pyridiner | |
| SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
| SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
| SE431545B (sv) | Forfarande for framstellning av nya 2-substituerade oxazolopyridiner | |
| SE427839B (sv) | Analogiforfaranden for framstellning av n-aryl-n-(1-l-4-piperidinyl)-aryl-acetamider | |
| NO139555C (no) | Fremgangsmaate for fremstilling av fosgen | |
| NO146058C (no) | Analogifremgangsmaate for fremstilling av substituerte benzamider | |
| SE432763B (sv) | Forfarande for framstellning av nya homoftalimider | |
| SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
| SE435716B (sv) | Forfarande for framstellning av nya penicilliner | |
| SE427841B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
| SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
| SE7606815L (sv) | Forfarande for framstellning av nya naftacenderivat | |
| SE409868B (sv) | Forfarande for framstellning av nya triaminoandrostaner | |
| SE420730B (sv) | Analogiforfarande for framstellning av nya pentacykliska foreningar | |
| SE421793B (sv) | Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat | |
| SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
| SE427840B (sv) | Analogiforfarande for framstellning av tienamycinderivat | |
| SE431979B (sv) | Forfarande for framstellning av nya omega-aminoalkansyraarylamider | |
| SE7610637L (sv) | Forfarande for framstellning av 2-alkylindaner | |
| SE446726B (sv) | Forfarande for framstellning av 16-metoxiprostaglandiner | |
| SE434952B (sv) | Forfarande for framstellning av nya cefalosporinderivat | |
| SE427558B (sv) | Analogiforfarande for framstellning av 7-metoxicefalosporinderivat | |
| SE7603682L (sv) | Forfarande for framstellning av en eteriskt substituerad monosackarid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |
Ref document number: 7608037-3 Effective date: 19920210 Format of ref document f/p: F |